Miliary tuberculosis occurred after immunosuppressive drug in PNH patient with completely cured tuberculosis; a case report

Annals of Clinical Microbiology and Antimicrobials

Volumn 11, Issue , 2012, Pages

  Lee, Jihyun ^a   Gong, Soojung ^a   Lee, Byounghoon ^a   Lee, Soyoung ^a   Lee, Jungae ^a   Kim, Naeyu ^a  

^a Eulji University School of Medicine   (South Korea)

Author keywords

Miliary tuberculosis (TB); Paroxysmal nocturnal hemoglobinuria; Tuberculosis (TB) prophylaxis

Indexed keywords

CORTICOSTEROID; DANAZOL; ETHAMBUTOL; ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; ISONIAZID; RIFAMPICIN;

ADULT; ANTIBIOTIC THERAPY; APLASTIC ANEMIA; ARTICLE; ASIAN; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; FEVER; HEMATURIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TUBERCULOSIS; MALE; MILIARY TUBERCULOSIS; OXYGEN MASK; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; THORAX RADIOGRAPHY; WEAKNESS;

ADULT; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LATENT TUBERCULOSIS; MALE; RECURRENCE; TUBERCULOSIS, MILIARY;

EID: 84860355836     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-11-12     Document Type: Article

References (19)

1. Rachidi S, Musallam KM, Taher AT. A closer look at paroxysmal nocturnal hemoglobinuria. Eur J Intern Med 2010, 21:260-267. 10.1016/j.ejim.2010.04.002, 20603032.
2. Brodsky RA. How I treat paroxysmal nocturnal hemoglobinuria. Blood 2009, 113:6522-6527. 10.1182/blood-2009-03-195966, 2710914, 19372253.
3. Parker CJ, Brodsky RA, Levine JE. Treatment versus transplant for challenging hematologic disorders. Biol Blood Marrow Transplant 2009, 15:72-78.
4. Centers for Disease Control and Prevention (CDC) Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR 2000, 49:1-51. Centers for Disease Control and Prevention (CDC).
5. Sharma SK, Mohan A, Sharma A, Mitra DK. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 2005, 5:415-430. 10.1016/S1473-3099(05)70163-8, 15978528.
6. Falk A, Fuchs GF. Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration Cooperative Study XII. Chest 1978, 73:44-48. 10.1378/chest.73.1.44, 340155.
7. Kim JS, Lee JW, Kim BK, Lee JH, Chung J. The use of the complement inhibitor eculizumab (Soliris(R)) for treating Korean patients with paroxysmal nocturnal hemoglobinuria. Korean J Hematol 2010, 45:269-274. 10.5045/kjh.2010.45.4.269, 3023054, 21253430.
8. Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, Roth A, Szer J, Elebute MO, Nakamura R, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006, 355:1233-1243. 10.1056/NEJMoa061648, 16990386.
9. Shim TS, Koh WJ, Yim JJ, Lew WJ. Treatment of Latent Tuberculosis Infection in Korea. Tubercul Respir Dis 2008, 65:79-90.
10. Lobue P, Menzies D. Treatment of latent tuberculosis infection: an update. Respirology 2010, 15:603-622. 10.1111/j.1440-1843.2010.01751.x, 20409026.
11. World Health Organization Global Tuberculosis Control: A Short Update to the 2009 Report 2009, , , World Health Organization.
12. Shim TS. Comparison of guidelines for the management of tuberculosis: Korea, United States, and World Health Organization. J Korean Med Sci 2006, 49:781-789.
13. Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002, 347:1860-1866. 10.1056/NEJMcp021045, 12466511.
14. Bhatt K, Salgame P. Host innate immune response to Mycobacterium tuberculosis. J Clin Immunol 2007, 27:347-362. 10.1007/s10875-007-9084-0, 17364232.
15. Silva FA, Matos JO, de QMFC, Nucci M. Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances. Haematologica 2005, 90:1110-1115.
16. Hahn JS, Lee YC, Kim YK, Lee SJ, Ko YW, Chang J, Lee WY. Clinical study on tuberculosis in patients with hematologic disease. Korean J Hematol 1990, 25:161-169.
17. World Health Organization (WHO) WHO report 2010 Global tuberculosis control. WHO report 2012 2010, 1-218. World Health Organization (WHO).
18. Sugino K, Gocho K, Ota H, Kobayashi M, Sano G, Isobe K, Takai Y, Izumi H, Kuraishi Y, Shibuya K, Homma S. Miliary tuberculosis associated with chronic neutrophilic leukemia. Intern Med 2009, 48:1283-1287. 10.2169/internalmedicine.48.2080, 19652431.
19. Neonakis IK, Alexandrakis MG, Gitti Z, Tsirakis G, Krambovitis E, Spandidos DA. Miliary tuberculosis with no pulmonary involvement in myelodysplastic syndromes: a curable, yet rarely diagnosed, disease: case report and review of the literature. Ann Clin Microbiol Antimicrob 2008, 7:8. 10.1186/1476-0711-7-8, 2276236, 18339200.